Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Thalidomide to Treat Oral Lesions in HIV-Infected Patients
This study has been completed.
Study NCT00001524 Information provided by National Institutes of Health Clinical Center (CC)
First Received: November 3, 1999 Last Updated: March 3, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Acquired Immunodeficiency Syndrome
Burning Mouth Syndrome
HIV Infection
Additional conditions recognized in this trial
HIV Infections
Immunologic Deficiency Syndromes
Infection
Syndrome
More general conditions related to this trial
Disease
Immune System Diseases
Lentivirus Infections
Mouth Diseases
Pathologic Processes
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Stomatognathic Diseases
Virus Diseases
Interventions listed in this trial
Thalidomide
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Anti-Bacterial Agents
Anti-Infective Agents
Antineoplastic Agents
Growth Inhibitors
Growth Substances
Immunologic Factors
Immunosuppressive Agents
Leprostatic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute of Dental and Craniofacial Research (NIDCR)
Back to top of Main Content
